Home / Transcripts / Jeena Sikho Lifecare Limited (JSLL) · May 20, 2025

Jeena Sikho Lifecare Limited (JSLL) Earnings Call Transcript

May 20, 2025

National Stock Exchange of India IN Health Care Health Care Providers and Services earnings 81 min

Earnings Call Speaker Segments

Operator operator
#1

Ladies and gentlemen, welcome to the Jeena Sikho Lifecare Limited H2 FY '25 and FY '25 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to hand the conference over to Mr. Ranvir Singh from Nuvama Wealth and Investment Limited. Thank you, and over to you, sir.

Ranvir Singh analyst
#2

Yes. Thank you, moderator. So on behalf of Jeena Sikho Lifecare Limited, I extend a very warm welcome to all participants on the H2 FY '25 and Full Year FY '25 Financial Results Discussion Call. Today on our call, we have Acharya Manish Grover-ji, Managing Director; and Mr. Nanak Chand, CFO. Before bringing with this call, I would like to give a short disclaimer. This call may contain some of the forward-looking statements, which are completely based upon management's beliefs, opinions, and expectations as of today. These statements are not a guarantee of company's future performance and involve unforeseen risks and uncertainties. With this, I would like to hand over this call to Acharya for his opening remarks. Over to you, sir.

Manish Grover executive
#3

[Foreign Language]

Nanak Chand executive
#4

Thank you, Manish sir. Good afternoon, everyone. As mentioned by Manish sir, we have achieved a healthy financial performance during the H2 FY '25 and FY '25. Here, there are these key highlights of H2 FY '25 results. Our revenue grew by 53% on Y-o-Y basis, that is INR 255 crores in H2 FY '25. The EBITDA during the H2 FY '25 grew by 36% Y-o-Y rate INR 65.60 crores, implying the EBITDA margin of 26%. The H2 FY '25 PAT grew by 17% Y-o-Y INR 43.85 crores. Now FY '25 results, the revenue from the operations grew by 45% Y-o-Y to INR 469 crores. Given why the hospital service business, which is grew by 83% Y-o-Y, that is 253.80 crores, while the product sales grew by 16% to INR 215.27 crores. The EBITDA during the FY '25 grew by 34% Y-o-Y to INR 124.88 crores, implying to EBITDA margin, 27%. The FY '25 PAT grew by 31% Y-o-Y to reach INR 90.73 crores. We maintained a healthy balance sheet with the net cash equivalent to INR 26 crores by the end of the FY '25 or FY '25. Our ROE and ROCE stood 39% and 63%, respectively. We spent INR 42 crores CapEx in FY '25. With this, we can open the floor for the question and answers. Thank you.

Operator operator
#5

[Operator Instructions] First question is from the line of Agastya Dave from CAO Capital.

Agastya Dave analyst
#6

Am I audible?

Operator operator
#7

Yes, sir, please go ahead.

Agastya Dave analyst
#8

[Foreign Language]

Manish Grover executive
#9

[Foreign Language]

Agastya Dave analyst
#10

[Foreign Language]

Manish Grover executive
#11

[Foreign Language]

Agastya Dave analyst
#12

[Foreign Language]

Manish Grover executive
#13

[Foreign Language]

Agastya Dave analyst
#14

[Foreign Language]

Manish Grover executive
#15

[Foreign Language]

Agastya Dave analyst
#16

[Foreign Language]

Manish Grover executive
#17

[Foreign Language]

Agastya Dave analyst
#18

[Foreign Language] margin attributable to increased cost of procurement for some consumables and medicines. [Foreign Language]

Manish Grover executive
#19

[Foreign Language]

Operator operator
#20

Next question is from the line of Abishek from AB Capital.

Unknown Analyst analyst
#21

[Foreign Language]

Manish Grover executive
#22

[Foreign Language]

Unknown Analyst analyst
#23

Okay, sir. Okay, sir. [Foreign Language]

Manish Grover executive
#24

[Foreign Language]

Unknown Analyst analyst
#25

[Foreign Language]

Manish Grover executive
#26

[Foreign Language]

Unknown Analyst analyst
#27

Okay. Okay. [Foreign Language]

Manish Grover executive
#28

[Foreign Language]

Unknown Analyst analyst
#29

[Foreign Language]

Manish Grover executive
#30

[Foreign Language]

Unknown Analyst analyst
#31

Okay, sir. [Foreign Language]

Manish Grover executive
#32

[Foreign Language]

Unknown Analyst analyst
#33

Okay, sir. [Foreign Language]

Manish Grover executive
#34

[Foreign Language]

Operator operator
#35

[Operator Instructions] Next question is from the line of Akshay from AK Investment.

Akshay Kaila analyst
#36

[Foreign Language]

Manish Grover executive
#37

[Foreign Language]

Akshay Kaila analyst
#38

Okay. [Foreign Language]

Manish Grover executive
#39

[Foreign Language]

Akshay Kaila analyst
#40

[Foreign Language]

Manish Grover executive
#41

[Foreign Language]

Operator operator
#42

Next question is from the line of Naveen Baid from Nuvama Asset Management.

Naveen Baid analyst
#43

[Foreign Language]

Manish Grover executive
#44

[Foreign Language]

Naveen Baid analyst
#45

[Foreign Language]

Manish Grover executive
#46

[Foreign Language]

Naveen Baid analyst
#47

Okay. [Foreign Language]

Manish Grover executive
#48

[Foreign Language]

Naveen Baid analyst
#49

[Foreign Language]

Manish Grover executive
#50

[Foreign Language]

Naveen Baid analyst
#51

[Foreign Language]

Manish Grover executive
#52

[Foreign Language]

Naveen Baid analyst
#53

[Foreign Language]

Manish Grover executive
#54

[Foreign Language]

Naveen Baid analyst
#55

[Foreign Language]

Manish Grover executive
#56

[Foreign Language]

Naveen Baid analyst
#57

[Foreign Language]

Manish Grover executive
#58

[Foreign Language]

Operator operator
#59

Next question is from the line of Prerana Amanna from Equity Research Program.

Prerana Nireeksha Amanna analyst
#60

Congratulations on a great set of numbers. [Foreign Language] We had a target of 25% this year. [Foreign Language] FY '26, can we reach that 25% of PAT margin?

Manish Grover executive
#61

[Foreign Language]

Prerana Nireeksha Amanna analyst
#62

[Foreign Language]

Manish Grover executive
#63

[Foreign Language]

Prerana Nireeksha Amanna analyst
#64

[Foreign Language]

Manish Grover executive
#65

[Foreign Language]

Prerana Nireeksha Amanna analyst
#66

[Foreign Language]

Manish Grover executive
#67

[Foreign Language]

Prerana Nireeksha Amanna analyst
#68

[Foreign Language]

Manish Grover executive
#69

[Foreign Language]

Prerana Nireeksha Amanna analyst
#70

[Foreign Language]

Operator operator
#71

Next question is from the line of Pravesh Kothari from Kothari Investment and Infrastructure.

Pravesh Kothari analyst
#72

[Foreign Language]

Manish Grover executive
#73

[Foreign Language]

Pravesh Kothari analyst
#74

[Foreign Language]

Manish Grover executive
#75

[Foreign Language]

Nanak Chand executive
#76

[Foreign Language]

Pravesh Kothari analyst
#77

[Foreign Language]

Manish Grover executive
#78

[Foreign Language]

Pravesh Kothari analyst
#79

[Foreign Language]

Manish Grover executive
#80

[Foreign Language]

Operator operator
#81

Next question is from the line of Akshit Agarwal from Akshit Agarwal HUF.

Unknown Analyst analyst
#82

[Foreign Language]

Manish Grover executive
#83

[Foreign Language]

Operator operator
#84

Next question is from the line of Amit Agarwal, an Individual Investor.

Unknown Attendee attendee
#85

Sir, am I audible?

Manish Grover executive
#86

Yes, sir.

Unknown Attendee attendee
#87

[Foreign Language]

Manish Grover executive
#88

[Foreign Language]

Unknown Attendee attendee
#89

[Foreign Language]

Manish Grover executive
#90

[Foreign Language]

Unknown Attendee attendee
#91

[Foreign Language]

Manish Grover executive
#92

[Foreign Language]

Operator operator
#93

Next question is from the line of Chirag Shah from White Pine Investment Manager.

Chirag Shah analyst
#94

[Foreign Language]

Manish Grover executive
#95

[Foreign Language]

Chirag Shah analyst
#96

[Foreign Language]

Manish Grover executive
#97

[Foreign Language]

Chirag Shah analyst
#98

[Foreign Language]

Manish Grover executive
#99

[Foreign Language]

Chirag Shah analyst
#100

[Foreign Language]

Manish Grover executive
#101

[Foreign Language]

Chirag Shah analyst
#102

[Foreign Language]

Manish Grover executive
#103

[Foreign Language]

Operator operator
#104

Next question is from the line of Nitin Gupta, an individual investor.

Unknown Attendee attendee
#105

Hello, am I audible?

Operator operator
#106

Yes, sir.

Manish Grover executive
#107

Yes, sir.

Unknown Attendee attendee
#108

[Foreign Language]

Manish Grover executive
#109

[Foreign Language]

Unknown Attendee attendee
#110

[Foreign Language]

Manish Grover executive
#111

[Foreign Language]

Unknown Attendee attendee
#112

[Foreign Language]

Manish Grover executive
#113

[Foreign Language]

Unknown Attendee attendee
#114

[Foreign Language]

Manish Grover executive
#115

[Foreign Language]

Operator operator
#116

Next question is from the line of Vivi Agarwal from FICAM Family Office.

Unknown Analyst analyst
#117

[Foreign Language]

Operator operator
#118

Mr. Agarwal, we're not able to hear you clearly.

Unknown Analyst analyst
#119

Am I audible?

Manish Grover executive
#120

[Foreign Language]

Unknown Analyst analyst
#121

[Foreign Language]

Manish Grover executive
#122

[Foreign Language]

Unknown Analyst analyst
#123

[Foreign Language]

Manish Grover executive
#124

[Foreign Language]

Operator operator
#125

Next question is from the line of Keshav Lahoti from HDFC Securities.

Keshav Lahoti analyst
#126

[Foreign Language]

Manish Grover executive
#127

[Foreign Language]

Keshav Lahoti analyst
#128

Understood. [Foreign Language]

Manish Grover executive
#129

[Foreign Language]

Operator operator
#130

Next question is from the line of Gaurav Didwania from Cor Advisors LLP.

Gaurav Didwania analyst
#131

[Foreign Language]

Manish Grover executive
#132

[Foreign Language]

Gaurav Didwania analyst
#133

[Foreign Language]

Manish Grover executive
#134

[Foreign Language]

Gaurav Didwania analyst
#135

[Foreign Language]

Manish Grover executive
#136

[Foreign Language]

Gaurav Didwania analyst
#137

[Foreign Language]

Manish Grover executive
#138

[Foreign Language]

Gaurav Didwania analyst
#139

[Foreign Language]

Manish Grover executive
#140

[Foreign Language]

Gaurav Didwania analyst
#141

[Foreign Language]

Manish Grover executive
#142

[Foreign Language]

Gaurav Didwania analyst
#143

[Foreign Language]

Manish Grover executive
#144

[Foreign Language]

Gaurav Didwania analyst
#145

[Foreign Language]

Manish Grover executive
#146

[Foreign Language]

Operator operator
#147

Next question is from the line of Abhishek from AB Capital.

Unknown Analyst analyst
#148

[Foreign Language]

Manish Grover executive
#149

[Foreign Language]

Unknown Analyst analyst
#150

[Foreign Language]

Manish Grover executive
#151

[Foreign Language]

Operator operator
#152

Next question is from the line of Shalin Parikh from MYCPE One.

Shalin Parikh analyst
#153

Hello. [Foreign Language]

Manish Grover executive
#154

[Foreign Language]

Shalin Parikh analyst
#155

[Foreign Language]

Manish Grover executive
#156

[Foreign Language]

Shalin Parikh analyst
#157

[Foreign Language]

Manish Grover executive
#158

[Foreign Language]

Shalin Parikh analyst
#159

[Foreign Language]

Manish Grover executive
#160

[Foreign Language]

Operator operator
#161

Ladies and gentlemen, that was the last question of the day. I now hand the conference over to Mr. Ranvir Singh from Nuvama Wealth and Investment Limited. Over to you, sir.

Ranvir Singh analyst
#162

Thank you, all. Thank you for participation, and thank you, the management. Sir, Acharya-ji, you would like to [Foreign Language]

Manish Grover executive
#163

[Foreign Language]

Ranvir Singh analyst
#164

Moderator, we can close the call now.

Operator operator
#165

Okay, sir. On behalf of Nuvama Wealth & Investment Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Jeena Sikho Lifecare Limited transcript - plus 252,000+ transcripts from 12,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

Other Jeena Sikho Lifecare Limited earnings calls

Peers in Health Care

For developers and AI pipelines

Programmatic access to Jeena Sikho Lifecare Limited earnings transcripts and 252,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $105 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.